Circulating DNA in diagnosis and monitoring EGFR gene mutations in advanced non-small cell lung cancer

por Bordi, Paola, Del Re, Marzia, Danesi, Romano, Tiseo, Marcello
Publicado en Transl Lung Cancer Res (2015)

Detection of KRAS mutant alleles in circulating cell-free tumor DNA in colorectal cancer patients resistant to cetuximab

por Del Re, Marzia, Ulivi, Paola, Passardi, Alessandro, Zoli, Wainer, Danesi, Romano, Amadori, Dino
Publicado 2014

Clinical pharmacology of intravitreal anti-VEGF drugs

por Fogli, Stefano, Del Re, Marzia, Rofi, Eleonora, Posarelli, Chiara, Figus, Michele, Danesi, Romano
Publicado en Eye (Lond) (2018)

Pharmacogenetic Foundations of Therapeutic Efficacy and Adverse Events of Statins

por Arrigoni, Elena, Del Re, Marzia, Fidilio, Leonardo, Fogli, Stefano, Danesi, Romano, Di Paolo, Antonello
Publicado en Int J Mol Sci (2017)

Unusual gastrointestinal and cutaneous toxicities by bleomycin, etoposide, and cisplatin: a case report with pharmacogenetic analysis to personalize treatment

por Del Re, Marzia, Latiano, Tiziana, Fidilio, Leonardo, Restante, Giuliana, Morelli, Franco, Maiello, Evaristo, Danesi, Romano
Publicado en EPMA J (2017)

Radiomics and liquid biopsy in oncology: the holons of systems medicine

por Neri, Emanuele, Del Re, Marzia, Paiar, Fabiola, Erba, Paola, Cocuzza, Paola, Regge, Daniele, Danesi, Romano
Publicado en Insights Imaging (2018)

Editorial: Liquid Biopsy as a Tool for Precision Oncology: New Challenges to Assess Clinical Response

por Ravegnini, Gloria, Del Re, Marzia, Grolla, Ambra A., van Schaik, Ron H. N., Angelini, Sabrina
Publicado en Front Pharmacol (2020)

Discovery of novel mutations in the dihydropyrimidine dehydrogenase gene associated with toxicity of fluoropyrimidines and viewpoint on preemptive pharmacogenetic screening in pati...

por Del Re, Marzia, Michelucci, Angela, Di Leo, Angelo, Cantore, Maurizio, Bordonaro, Roberto, Simi, Paolo, Danesi, Romano
Publicado en EPMA J (2015)

Are anti-PD1 and anti-PD-L1 alike? The non-small-cell lung cancer paradigm

por Banna, Giuseppe Luigi, Cantale, Ornella, Bersanelli, Melissa, Del Re, Marzia, Friedlaender, Alex, Cortellini, Alessio, Addeo, Alfredo
Publicado en Oncol Rev (2020)

Dihydropyrimidine dehydrogenase polymorphisms and fluoropyrimidine toxicity: ready for routine clinical application within personalized medicine?

por Del Re, Marzia, Di Paolo, Antonello, van Schaik, Ron H., Bocci, Guido, Simi, Paolo, Falcone, Alfredo, Danesi, Romano
Publicado 2010

Genetic variation: effect on prostate cancer

por Sissung, Tristan M., Price, Douglas K., Del Re, Marzia, Ley, Ariel M., Giovannetti, Elisa, Figg, William D., Danesi, Romano
Publicado en Biochim Biophys Acta (2014)

The increase in activating EGFR mutation in plasma is an early biomarker to monitor response to osimertinib: a case report

por Del Re, Marzia, Rofi, Eleonora, Cappelli, Carla, Puppo, Gianfranco, Crucitta, Stefania, Valeggi, Simona, Chella, Antonio, Danesi, Romano, Petrini, Iacopo
Publicado en BMC Cancer (2019)

Implications of KRAS mutations in acquired resistance to treatment in NSCLC

por Del Re, Marzia, Rofi, Eleonora, Restante, Giuliana, Crucitta, Stefania, Arrigoni, Elena, Fogli, Stefano, Di Maio, Massimo, Petrini, Iacopo, Danesi, Romano
Publicado en Oncotarget (2017)

Nanopore sequencing from liquid biopsy: analysis of copy number variations from cell-free DNA of lung cancer patients

por Martignano, Filippo, Munagala, Uday, Crucitta, Stefania, Mingrino, Alessandra, Semeraro, Roberto, Del Re, Marzia, Petrini, Iacopo, Magi, Alberto, Conticello, Silvestro G.
Publicado en Mol Cancer (2021)

Clinical CYP2D6 Genotyping to Personalize Adjuvant Tamoxifen Treatment in ER-Positive Breast Cancer Patients: Current Status of a Controversy

por Mulder, Tessa A. M., de With, Mirjam, del Re, Marzia, Danesi, Romano, Mathijssen, Ron H. J., van Schaik, Ron H. N.
Publicado en Cancers (Basel) (2021)

Concise Review: Chronic Myeloid Leukemia: Stem Cell Niche and Response to Pharmacologic Treatment

por Arrigoni, Elena, Del Re, Marzia, Galimberti, Sara, Restante, Giuliana, Rofi, Eleonora, Crucitta, Stefania, Baratè, Claudia, Petrini, Mario, Danesi, Romano, Di Paolo, Antonello
Publicado en Stem Cells Transl Med (2018)

erbB in NSCLC as a molecular target: current evidences and future directions

por Del Re, Marzia, Cucchiara, Federico, Petrini, Iacopo, Fogli, Stefano, Passaro, Antonio, Crucitta, Stefania, Attili, Ilaria, De Marinis, Filippo, Chella, Antonio, Danesi, Romano
Publicado en ESMO Open (2020)

Early changes in plasma DNA levels of mutant KRAS as a sensitive marker of response to chemotherapy in pancreatic cancer

por Del Re, Marzia, Vivaldi, Caterina, Rofi, Eleonora, Vasile, Enrico, Miccoli, Mario, Caparello, Chiara, d’Arienzo, Paolo Davide, Fornaro, Lorenzo, Falcone, Alfredo, Danesi, Romano
Publicado en Sci Rep (2017)

Dabrafenib treatment in a patient with BRAF V600E ganglioglioma: circulating exosome-derived cancer RNA supports treatment choice and clinical monitoring

por Pasqualetti, Francesco, Restante, Giuliana, Gonnelli, Alessandra, Rofi, Eleonora, Molinari, Alessandro, Crucitta, Stefania, Paiar, Fabiola, Rudà, Roberta, Danesi, Romano, Soffietti, Riccardo, Del Re, Marzia
Publicado en Neuro Oncol (2019)

Multiple Resistance Mechanisms to Tyrosine Kinase Inhibitors in EGFR Mutated Lung Adenocarcinoma: A Case Report Harboring EGFR Mutations, MET Amplification, and Squamous Cell Trans...

por Bruno, Rossella, Del Re, Marzia, Cucchiara, Federico, Petrini, Iacopo, Alì, Greta, Crucitta, Stefania, Proietti, Agnese, Valleggi, Simona, Chella, Antonio, Danesi, Romano, Fontanini, Gabriella
Publicado en Front Oncol (2021)